Therapeutics XIX. Lipid lowering agents.
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy; D001796:Blood Protein Disorders / Q000188:drug therapy / Q000628:therapy; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy; D004035:Diet Therapy; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D050356:Lipid Metabolism; D008074:Lipoproteins / Q000097:blood; D008659:Metabolic Diseases / Q000188:drug therapy; D009539:Nicotinic Acids / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood; D014973:Xanthomatosis / Q000188:drug therapy / Q000209:etiology
D000960:Hypolipidemic Agents; D008074:Lipoproteins; D009539:Nicotinic Acids; D014280:Triglycerides; D002792:Cholestyramine Resin; D002994:Clofibrate